JPH033664B2 - - Google Patents

Info

Publication number
JPH033664B2
JPH033664B2 JP57057727A JP5772782A JPH033664B2 JP H033664 B2 JPH033664 B2 JP H033664B2 JP 57057727 A JP57057727 A JP 57057727A JP 5772782 A JP5772782 A JP 5772782A JP H033664 B2 JPH033664 B2 JP H033664B2
Authority
JP
Japan
Prior art keywords
methyl
compound
reaction
cyano
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP57057727A
Other languages
Japanese (ja)
Other versions
JPS58174370A (en
Inventor
Dotaro Fujimoto
Giichi Funatsukuri
Koichi Seki
Takeshi Sakai
Shuhei Takamatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujimoto Pharmaceutical Corp
Original Assignee
Fujimoto Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Pharmaceutical Corp filed Critical Fujimoto Pharmaceutical Corp
Priority to JP57057727A priority Critical patent/JPS58174370A/en
Publication of JPS58174370A publication Critical patent/JPS58174370A/en
Publication of JPH033664B2 publication Critical patent/JPH033664B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】 本発明は、シアノグアニジン誘導体、特に下式
〔〕で示されるN−シアノ−N′−メチル−N″−
2−[[(4−メチル−5−イミダゾリル)メチル]
チオ]エチルグアニジンの製造方法に関する。
Detailed Description of the Invention The present invention relates to cyanoguanidine derivatives, particularly N-cyano-N'-methyl-N''-
2-[[(4-methyl-5-imidazolyl)methyl]
The present invention relates to a method for producing thio]ethylguanidine.

本発明の目的化合物〔〕は一般名をシメチジ
ン(cimetidine)と称せられ、ヒスタミンのH2
一受容体遮断効果を有し抗潰瘍剤として広く知ら
れているものである。
The object compound of the present invention [ ] has a generic name called cimetidine, and has the H 2
It has a receptor blocking effect and is widely known as an anti-ulcer agent.

従来、シメチジンの製造法については種々提案
されているが(特開昭54−59275号、同51−
54561、同51−125074号、同50−32174号、特開昭
56−1309号等)、いずれも反応試剤として高価な
システアミン(HSCH2CH2NH2)を必要とし、
かつその反応生成物はクロマトグラフイーによる
分離精製を要する等、工業的な製造法とは言えな
い。また、4−メチル−5−メルカプトメチルイ
ミダゾールを原料とする製造法(特開昭54−
130566号)では、該原料がアルカリ性条件下で酸
化され易いため収率の抵下を免れ得ず、多量の副
生成が分離精製を困難にするという欠点がある。
Until now, various methods for producing cimetidine have been proposed (Japanese Patent Application Laid-open Nos. 54-59275 and 51-59).
54561, No. 51-125074, No. 50-32174, JP-A-Sho
56-1309, etc.), all of which require expensive cysteamine (HSCH 2 CH 2 NH 2 ) as a reaction reagent,
Moreover, the reaction product requires separation and purification by chromatography, so it cannot be called an industrial production method. In addition, a manufacturing method using 4-methyl-5-mercaptomethylimidazole as a raw material (Japanese Patent Application Laid-open No.
No. 130566) has the drawback that the raw material is easily oxidized under alkaline conditions, resulting in a decrease in yield, and a large amount of by-products make separation and purification difficult.

本発明は、上記欠点を克服すべくなされたもの
であり、1反応工程にて高収率で目的化合物
〔〕を製造する方法を提供する。
The present invention has been made to overcome the above-mentioned drawbacks, and provides a method for producing the target compound in high yield in one reaction step.

本発明方法によれば、下式〔〕 で示される4−メチル−5−(N−メチルカルバ
モイルオキシ)メチル−イミダゾールと、下式
〔〕 で示されるN−シアノ−N′、S−エチレンイソ
チオウレアとを、塩基性条件下に反応させて目的
化合物であるシメチジン〔〕を得る。
According to the method of the present invention, the following formula [] 4-methyl-5-(N-methylcarbamoyloxy)methyl-imidazole represented by the following formula [] The desired compound, cimetidine, is obtained by reacting N-cyano-N', S-ethyleneisothiourea represented by the formula under basic conditions.

上記反応における塩基性条件は、例えば水酸化
ナトリウム、水酸化カリウム、水酸化カルシウム
などのアルカリ金属またはアルカリ土類金属の水
酸化物、あるいはナトリウムエトキシド、カリウ
ムエトキシドなどのアルカリ金属アルコキサイド
などによつてもたらされる。反応は、溶媒中、常
圧もしくは加圧条件下、加熱もしくは常温で行な
われる。反応溶媒の例としては、水、メタノー
ル、エタノール、アセトン、アセトニトリル、ジ
メチルホルムアミド(DMF)、ジメチルスルホキ
シド(DMSO)など、あるいはこれらの混合溶
媒が挙げられる。
The basic conditions in the above reaction are, for example, hydroxides of alkali metals or alkaline earth metals such as sodium hydroxide, potassium hydroxide, and calcium hydroxide, or alkali metal alkoxides such as sodium ethoxide and potassium ethoxide. It will be brought to you. The reaction is carried out in a solvent, under normal pressure or pressurized conditions, with heating or at room temperature. Examples of the reaction solvent include water, methanol, ethanol, acetone, acetonitrile, dimethylformamide (DMF), dimethyl sulfoxide (DMSO), and a mixed solvent thereof.

本発明に用いられるイミダゾール誘導体〔〕 は、*印の炭素がカルボニル基より求核攻撃を受
け易く、求核攻撃により遊離するN−メチルカル
バミン酸は容易に脱炭酸を受けて、CO2
NH2CH3に分離する。一方、環状イソチオウレ
ア誘導体〔〕は、上記化合物〔〕に対する求
核試剤として、その*印の炭素に求核的に作用
し、それにより生ずるメチルアミンが反応に関与
することによつて目的化合物であるシメチジン
〔〕が1反応工程にて高収率で得られる。
Imidazole derivative used in the present invention [] The carbon marked with * is more susceptible to nucleophilic attack than the carbonyl group, and the N-methylcarbamic acid liberated by the nucleophilic attack is easily decarboxylated and converted into CO 2 and
Separate into NH2CH3 . On the other hand, the cyclic isothiourea derivative [ ] acts nucleophilically on the carbon marked with * as a nucleophilic reagent for the above compound [ ], and the methylamine generated thereby participates in the reaction to form the target compound. A certain cimetidine [ ] can be obtained in high yield in one reaction step.

なお、環状イソチオウレア誘導体〔〕は、メ
ルカプト基が保護された化学構造であり、塩基性
条件下においても耐酸化性を有するので、化合物
〔〕との反応において従来法のような副反応生
成物を生じることがなく、目的化合物〔〕の分
離精製も容易である。
The cyclic isothiourea derivative [] has a chemical structure with a protected mercapto group and has oxidation resistance even under basic conditions, so it does not produce side reaction products when reacting with the compound [] as in conventional methods. The separation and purification of the target compound [] is also easy.

次に実施例について説明するが、本発明方法は
これに限定されるものではない。
Next, examples will be described, but the method of the present invention is not limited thereto.

実施例(化合物〔〕+化合物〔〕→化合物
〔〕) エタノール50mlに水酸化ナトリウム2g(0.05
モル)を溶解し、これにN−シアノ−N′、S−
エチレンイソチオウレア(化合物〔〕)6.4g
(0.05モル)を加え、20分間攪拌し、ついで4−
メチル−5−(N−メチルカルバモイルオキシ)
メチル−イミダゾール(化合物〔〕)8.45g
(0.05モル)を一度に加え、60〜70℃で1時間攪
拌する。
Example (Compound [] + Compound [] → Compound []) 2 g of sodium hydroxide in 50 ml of ethanol (0.05
mol), and to this dissolve N-cyano-N', S-
Ethyleneisothiourea (compound []) 6.4g
(0.05 mol) and stirred for 20 minutes, then 4-
Methyl-5-(N-methylcarbamoyloxy)
Methyl-imidazole (compound []) 8.45g
(0.05 mol) at once and stirred at 60-70°C for 1 hour.

反応液を留去したのち、2N水酸化ナトリウム
水溶液と酢酸エチルで振とうし、酢酸エチル相を
乾燥留去する。残渣をアセトニトリルとエーテル
の混合溶媒から結晶化させて目的とするシメチジ
ン〔〕を得る。6.9g(55%)。融点:139〜141
℃。
After the reaction solution was distilled off, the mixture was shaken with a 2N aqueous sodium hydroxide solution and ethyl acetate, and the ethyl acetate phase was dried and distilled off. The residue is crystallized from a mixed solvent of acetonitrile and ether to obtain the desired cimetidine. 6.9g (55%). Melting point: 139-141
℃.

Claims (1)

【特許請求の範囲】[Claims] 1 4−メチル−5−(N−メチルカルバモイル
オキシ)メチル−イミダゾールと、N−シアノ−
N′、S−エチレンイソチオウレアとを、塩基性
条件下に反応させて、N−シアノ−N′−メチル
−N″−2−[[(4−メチル−5−イミダゾリル)
メチル〕チオ〕エチルグアニジンを得ることを特
徴とするシアノグアニジン誘導体の製造法。
1 4-Methyl-5-(N-methylcarbamoyloxy)methyl-imidazole and N-cyano-
N′,S-ethyleneisothiourea is reacted under basic conditions to produce N-cyano-N′-methyl-N″-2-[[(4-methyl-5-imidazolyl).
A method for producing a cyanoguanidine derivative, which comprises obtaining methyl]thio]ethylguanidine.
JP57057727A 1982-04-06 1982-04-06 Production of cyanogyanidine derivative Granted JPS58174370A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57057727A JPS58174370A (en) 1982-04-06 1982-04-06 Production of cyanogyanidine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57057727A JPS58174370A (en) 1982-04-06 1982-04-06 Production of cyanogyanidine derivative

Publications (2)

Publication Number Publication Date
JPS58174370A JPS58174370A (en) 1983-10-13
JPH033664B2 true JPH033664B2 (en) 1991-01-21

Family

ID=13063956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57057727A Granted JPS58174370A (en) 1982-04-06 1982-04-06 Production of cyanogyanidine derivative

Country Status (1)

Country Link
JP (1) JPS58174370A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1762899A1 (en) 2005-09-12 2007-03-14 Ricoh Company, Ltd. Latent electrostatic image bearing member, and the method for producing the same, image forming method, image forming apparatus, and process cartridge

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2607369B2 (en) * 1987-02-20 1997-05-07 興和株式会社 New heterocyclic compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1762899A1 (en) 2005-09-12 2007-03-14 Ricoh Company, Ltd. Latent electrostatic image bearing member, and the method for producing the same, image forming method, image forming apparatus, and process cartridge

Also Published As

Publication number Publication date
JPS58174370A (en) 1983-10-13

Similar Documents

Publication Publication Date Title
JPS5940829B2 (en) Process for producing mercaptoethyl-substituted guanidine
KR0140875B1 (en) Preparation of pyraozole and its derivatives
NO138408B (en) COMPOUND FOR USE AS A STARTING MATERIAL FOR THE PREPARATION OF 1- (4-METZYL-6-METHOXY-2-PYRIMIDINYL) -3-METHYL-5-METHOXYPYRAZOLE, AND PROCEDURE FOR PREPARING
JPH033664B2 (en)
JP4308667B2 (en) Method for preparing 1- (mercaptomethyl) -cyclopropaneacetic acid
JPH06102656B2 (en) Ranitidine manufacturing method
EP0018669B1 (en) 1-(2-sulfamoylaminoethyl)-1,4-dihydro-5h-tetrazole-5-thione and its salts
JP3082006B2 (en) Method for producing 2-alkylthio-4,6-dihydroxypyrimidine
KR870001539B1 (en) Preparing process for 4-methyl-5 thio amino-dimethyl imidazole dihydrochloro
EP0066440B1 (en) Chemical process
EP0071018B1 (en) Process for preparing 2,4-dihydroxypyrimidine (uracil)
JP2692923B2 (en) Process for producing imidazolidone derivative
JP3159860B2 (en) Method for synthesizing 4,5-diformylimidazole compound and novel imidazole compound
KR800000717B1 (en) Method of preparing n"-cyano-n-methyl-n'-(2-(5-methylimidazol-4-il)-methylthio)ethyl guanidine
JPS58188860A (en) Preparation of imidazole derivative
JPH033665B2 (en)
EP0015631A1 (en) ((4,5-Dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)thio)acetic acid and its salts
JPS636063B2 (en)
JPS622588B2 (en)
JP2585283B2 (en) Method for producing imidazole derivative
KR790001309B1 (en) Process for prepaing uracil derivatives
HU199410B (en) Process for producing 3-/alkyl-thio/-4-amino-1,2,4-triazin-5-on derivatives
JPH0532628A (en) Production of pyridylpyridone compound
JPH0696549B2 (en) Method for producing cyanoguanidine derivative
JPH04297452A (en) Production of thiocyanic acid esters